KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to -$427.0 million.

  • Gilead Sciences' Cash from Investing Activities rose 3985.92% to -$427.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 billion, marking a year-over-year increase of 1943.81%. This contributed to the annual value of -$3.4 billion for FY2024, which is 5227.37% down from last year.
  • Latest data reveals that Gilead Sciences reported Cash from Investing Activities of -$427.0 million as of Q3 2025, which was up 3985.92% from -$2.1 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Cash from Investing Activities registered a high of -$225.0 million during Q4 2024, and its lowest value of -$2.2 billion during Q1 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$483.0 million (2023), whereas its average is -$751.0 million.
  • In the last 5 years, Gilead Sciences' Cash from Investing Activities skyrocketed by 9690.32% in 2021 and then plummeted by 58925.08% in 2025.
  • Over the past 5 years, Gilead Sciences' Cash from Investing Activities (Quarter) stood at -$278.0 million in 2021, then crashed by 34.89% to -$375.0 million in 2022, then tumbled by 93.87% to -$727.0 million in 2023, then soared by 69.05% to -$225.0 million in 2024, then plummeted by 89.78% to -$427.0 million in 2025.
  • Its Cash from Investing Activities was -$427.0 million in Q3 2025, compared to -$2.1 billion in Q2 2025 and -$415.0 million in Q1 2025.